Warning! GuruFocus detected
4 Severe warning signs
with SVE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Synthaverse SA
NAICS : 325412
SIC : 2834
ISIN : PLBMDLB00018
Description
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 5.12 | |||||
| Interest Coverage | 3.91 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.23 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.9 | |||||
| 3-Year EBITDA Growth Rate | 3.9 | |||||
| 3-Year EPS without NRI Growth Rate | -0.9 | |||||
| 3-Year FCF Growth Rate | -296.2 | |||||
| 3-Year Book Growth Rate | 38.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.94 | |||||
| 9-Day RSI | 24.81 | |||||
| 14-Day RSI | 32.48 | |||||
| 3-1 Month Momentum % | 6.15 | |||||
| 6-1 Month Momentum % | 9.58 | |||||
| 12-1 Month Momentum % | 18.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | |||||
| Quick Ratio | 0.62 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 220.06 | |||||
| Days Sales Outstanding | 133.38 | |||||
| Days Payable | 210.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.2 | |||||
| Shareholder Yield % | -15.84 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.88 | |||||
| Operating Margin % | 14.09 | |||||
| Net Margin % | 7.1 | |||||
| FCF Margin % | -91.84 | |||||
| ROE % | 3.97 | |||||
| ROA % | 1.62 | |||||
| ROIC % | 2.53 | |||||
| 3-Year ROIIC % | -0.16 | |||||
| ROC (Joel Greenblatt) % | 3.56 | |||||
| ROCE % | 3.53 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.38 | |||||
| PE Ratio without NRI | 71.61 | |||||
| PS Ratio | 4.99 | |||||
| PB Ratio | 2.75 | |||||
| Price-to-Tangible-Book | 2.78 | |||||
| Price-to-Operating-Cash-Flow | 21.45 | |||||
| EV-to-EBIT | 45.85 | |||||
| EV-to-EBITDA | 24.42 | |||||
| EV-to-Revenue | 6.09 | |||||
| EV-to-FCF | -6.78 | |||||
| Price-to-GF-Value | 0.78 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.19 | |||||
| Price-to-Graham-Number | 2.98 | |||||
| Earnings Yield (Greenblatt) % | 2.18 | |||||
| FCF Yield % | -18.89 | |||||
| Forward Rate of Return (Yacktman) % | 5.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synthaverse SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 62.656 | ||
| EPS (TTM) (zł) | 0.064 | ||
| Beta | 1.8 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.81 | ||
| Volatility % | 31.95 | ||
| 14-Day RSI | 32.48 | ||
| 14-Day ATR (zł) | 0.113657 | ||
| 20-Day SMA (zł) | 4.641 | ||
| 12-1 Month Momentum % | 18.18 | ||
| 52-Week Range (zł) | 3.95 - 5.93 | ||
| Shares Outstanding (Mil) | 70.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synthaverse SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synthaverse SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synthaverse SA Frequently Asked Questions
What is Synthaverse SA(WAR:SVE)'s stock price today?
The current price of WAR:SVE is zł4.32. The 52 week high of WAR:SVE is zł5.93 and 52 week low is zł3.95.
When is next earnings date of Synthaverse SA(WAR:SVE)?
The next earnings date of Synthaverse SA(WAR:SVE) is .
Does Synthaverse SA(WAR:SVE) pay dividends? If so, how much?
Synthaverse SA(WAR:SVE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers